The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara to treat large hemispheric infarction (LHI). The allowances encompass a claim for using ...

A large hemispheric infarction is a particularly severe type of ischemic stroke that affects a substantial portion of the brain. Treatment for LHI typically involves rapid revascularization ...

Remedy Pharmaceuticals’ phase 3 candidate, Cirara (intravenous glyburide) is being developed for large hemispheric infarction (LHI), a severe form of ischaemic stroke where brain swelling ...